Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

162

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 2mg	2mg (100KIU)	Injectable powder for solution+diluent	110,192,512 L.L
B02BD06	WILATE 500	BioHuman	Von Willebrand Factor - 500IU, Blood Coagulation Factor VIII - 500IU		Injectable powder for solution+diluent	32,399,164 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU		Injectable lyophilised powder for solution+diluent	35,032,787 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 2000IU	2000IU	Injectable powder for solution+solvent	298,171,406 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 1000IU	1000IU	Injectable powder for solution+solvent	149,006,276 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 500IU	500IU	Injectable powder for solution+solvent	76,080,435 L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 500IU	500IU	Injectable powder for solution+diluent	27,390,281 L.L
B02BD04	OCTANINE F	BioHuman	Plasma coagulation factor IX, human - 500IU	500IU	Injectable freeze dried powder + diluent	31,425,075 L.L
B02BD04	IMMUNINE	BioHuman	Plasma coagulation factor IX, human - 600IU	600IU	Injectable lyophilised powder for solution+diluent	20,506,214 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 1000IU	1000U (50U/ml)	Injectable powder for solution+solvent	79,869,612 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 500IU	500U (50U/ml)	Injectable powder for solution+solvent	40,480,699 L.L
B02BD02	ESPEROCT	BioTech	Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 1000IU/Vial	1000IU/Vial	Injectable powder for solution+diluent	75,761,046 L.L
B02BD02	ESPEROCT	BioTech	Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 500IU/Vial	500IU/Vial	Injectable powder for solution+diluent	38,126,657 L.L
B02BD02	XYNTHA	BioTech	Moroctocog alfa - 500IU	500IU	Injectable lyophilised powder for solution+diluent	23,067,288 L.L
B02BD02	RECOFACT VIII	BioTech	Moroctocog alfa - 500IU	500IU	Injectable powder for solution+diluent	12,049,005 L.L
B02BD02	NUWIQ	BioTech	Coagulation Factor VIII recombinant, human (Simoctogog alfa) - 500IU	500IU	Injectable powder for solution+diluent	47,418,699 L.L
B02BD02	NOVOEIGHT	BioTech	Turoctocog Alfa - 500IU	500IU	Injectable powder for solution+diluent	29,783,973 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	46,817,511 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	26,495,478 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	28,437,886 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,247,110 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	14,098,526 L.L
B02BD01	OCTAPLEX	BioHuman	Prothrombin complex, human (PPSB) - 500IU	500IU	Injectable powder for solution+diluent	35,220,164 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	13,394,024 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	24,369,850 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	53,437,592 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution	41,515,083 L.L
B02BB01	FIBRYGA	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution+solvent	40,915,563 L.L
B02BA01	KONAKION MM PEDIATRIC	B	Phytomenadione - 2mg/0.2ml	2mg/0.2ml	Solution	442,124 L.L
B02BA01	PHYTOMENADIONE (VITAMINE K1) PANPHARMA	G	Phytomenadione - 10mg/ml	10mg/ml	Solution	740,457 L.L

...

162

...